GlobeNewswire by notified

Agfa-Gevaert: Publication of a transparency notification (AOC) – Regulated information

Share

(Article 14 of the law of May 2, 2007 on the disclosure of significant shareholdings)


Mortsel, Belgium – October 11, 2019 – 5.40 p.m. CET

According to Agfa-Gevaert NV’s bylaws, the threshold as from which a shareholding needs to be disclosed, has been set at 3%, 5% and a multiple of 5%.

In conformity with the Law of May 2, 2007 regarding the disclosure of significant shareholdings in listed companies, Agfa-Gevaert (Euronext: AGFB) discloses the following declaration:

Active Ownership Capital S.à.r.l. has announced on April 18, 2019, that it managed a stake in Agfa-Gevaert as per April 12, 2019 of 23,069,853 voting rights or 13.42% (denominator is 171,851,042).

On this date, AOC Value S.A.S. individually held 13,402,784 voting rights or 7.80%.

On April 12, 2019, Active Ownership Fund SICAV-FIS SCS contributed 4,535,000 shares already held by it in Agfa-Gevaert NV to AOC Technology S.A.S., as a result of which AOC Technology S.A.S. directly holds 9,667,069 voting rights or 5.63% of Agfa-Gevaert, thus crossing the 5% threshold upwards.

The total amount of voting rights held by the controlled undertakings as described below equals 13.42%.

Full chain of controlled undertakings through which the holding is effectively held

On June 25, 2018, AOC Technology S.A.S., AOC Value S.A.S. and Active Ownership Fund SICAV-FIS SCS concluded an acting in concert agreement regarding the exercise of their voting rights in the issuer, Agfa-Gevaert NV.
AOC Technology S.A.S. and AOC Value S.A.S. are both controlled by Active Ownership Fund SICAV-FIS SCS.

Active Ownership Fund SICAV-FIS SCS was managed by Active Ownership Capital S.à.r.l., which is jointly controlled by two shareholders, Active Ownership Advisors GmbH and Active Ownership Investments Ltd.
Active Ownership Advisors GmbH is controlled by Florian Schuhbauer.
Active Ownership Investments Ltd. is controlled by Tamlino Import & Advisory LP, which is controlled by Tamlino lnvestmenls Ltd., which is controlled by Klaus Röhrig.

On October 1, 2019 however, an agreement was concluded by Active Ownership Fund SICAV-FIS SCS regarding the appointment of Active Ownership Corporation S.à.r.l. as AIFM for Active Ownership Fund SICAV-FIS SCS. Pursuant to this agreement and appointment, Active Ownership Corporation S.à.r.l. will exercise the voting rights with respect to shares held by Active Ownership FUND SICAV-FIS SCS.

Active Ownership Corporation S.à.r.l. is jointly controlled by Active Ownership Advisors GmbH and Active Ownership Investments Ltd. The control over these two shareholders has not changed since the last notification and remains as described above.

The majority of the voting rights in AOC Technology S.A.S. and AOC Value S.A.S. are exercised by Active Ownership Fund SICAV-FIS SCS.

The exercise of the voting rights in Active Ownership Fund SICAV-FIS SCS has been described above.

AOC Value S.A.S. and AOC Technology S.A.S. are sister companies, both controlled by Active Ownership FUNS SICAV-FIS SCS.

Additional information

By way of clarification, this is a notification regarding a transfer of voting rights. Because of an agreement regarding the transfer of voting rights by an indirect shareholder, there is indirectly a transfer of voting rights in the Issuer. More in particular, this notification is filed because there is a transfer of voting rights between Active Ownership Fund SICAV-FIS SCS and Active Ownership Corporation S.à.r.l.

Active Ownership Fund SICAV-FIS has appointed Active Ownership Corporation S.à.r.l. as AIFM pursuant to an agreement dated October 1, 2019. As a result of this agreement, Active Ownership Corporation S.à.r.l. can exercise the voting rights held with respect to shares held by Active Ownership Fund SICAV-FIS SCS in a discretionary manner. Active Ownership Fund SICAV-FIS SCS indirectly controls shares in the Issuer in accordance with the full chain of control described above and is in turn controlled in accordance with the description of the chain of control above. Other than the aforementioned transfer of voting rights, there have been no changes with respect to the control over the Issuer.

Notifications of important shareholdings to be made according to the Law of
May 2, 2007 or Agfa-Gevaert NV’s bylaws, should be sent to viviane.dictus@agfa.com.


About Agfa
The Agfa-Gevaert Group develops, manufactures and distributes an extensive range of analogue and digital imaging systems and IT solutions, mainly for the printing industry and the healthcare sector, as well as for specific industrial applications.

Agfa’s headquarters and parent company are located in Mortsel, Belgium.

The Agfa-Gevaert Group achieved a turnover of 2,247 million euro in 2018.

Contact:

Viviane Dictus

Director Corporate Communications

tel. ++32 0 3 444 7124

e-mail: viviane.dictus@agfa.com



Attachments

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Vaisala's Interim Report January–March 2024 to be published on May 3, 202416.4.2024 15:00:00 CEST | Press release

Vaisala Corporation Press release April 16, 2024, at 4:00 p.m. (EEST) Vaisala's Interim Report January–March 2024 to be published on May 3, 2024 Vaisala Corporation will publish its Interim Report January–March 2024 on Friday, May 3, 2024, at about 9:00 a.m. (Finnish time). The release will be available at vaisala.com/investors. The President and CEO's presentation will be published by 1:00 p.m. on the same day at vaisala.com/investors. Audiocast and teleconference An audiocast and a conference call for analysts, investors and media will be held in English on the same day starting at 1:00 p.m. (Finnish time). You can participate in the live audiocast via following link: https://vaisala.videosync.fi/q1-2024 Questions may be presented by participating in the teleconference. You can access the teleconference by registering on the link below. After the registration, you will receive an email with the dial-in numbers and a conference ID. https://palvelu.flik.fi/teleconference/?id=50048551 A

Calibre Announces Closing of C$115 Million Financing16.4.2024 14:41:32 CEST | Press release

Not for distribution to U.S. news wire services or dissemination in the United States. VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (“Calibre” or the “Company”) is pleased to announce that it has closed its previously announced bought deal financing (the “Offering”) for aggregate gross proceeds of C$115,147,200. Pursuant to the Offering, a total of 68,540,000 common shares of the Company (“Common Shares”), including 8,940,000 Common Shares issued pursuant to the exercise in full of the over-allotment option, were sold at a price of C$1.68 per Common Share. The Common Shares issued pursuant to the Offering were offered by way of a short form prospectus filed in all provinces and territories of Canada, except Québec. The Offering was conducted through a syndicate of underwriters comprised of BMO Capital Markets, as lead underwriter, and Canaccord Genuity Corp., Scotia Capital Inc., Haywood Securities Inc. and Cormark Securi

KALLELSE TILL ÅRSSTÄMMA I CORLINE BIOMEDICAL AB (PUBL)16.4.2024 14:40:36 CEST | Pressemelding

Aktieägarna i Corline Biomedical AB (publ), org.nr 556417-0743 ("Bolaget"), kallas härmed till årsstämma onsdagen den 15 maj 2024 klockan 14.00 i Advokatfirman Lindahls lokaler på Vaksalagatan 10 i Uppsala. Anmälan m.m. Aktieägare som önskar delta i årsstämman måste: dels vara registrerad i eget namn (inte förvaltarregistrerad) i den av Euroclear Sweden AB förda aktieboken måndagen den 6 maj 2024,dels anmäla sitt deltagande så att anmälan är Bolaget till handa senast måndagen den 13 maj 2024 (den s.k. avstämningsdagen). Anmälan kan göras via e-post till olle.sward.brattstrom@lindahl.se eller per post till adressen Advokatfirman Lindahl KB, att. Olle Swärd Brattström, Box 1203, 751 42 Uppsala. Vid anmälan uppges aktieägarens namn, person- eller organisationsnummer (eller motsvarande) och gärna adress, telefonnummer, aktieinnehav, uppgift om eventuella biträden (högst två), samt i förekommande fall uppgift om ställföreträdare eller ombud. Förvaltarregistrerade aktier Aktieägare som låtit

Resolutions of Marimekko Corporation’s Annual General Meeting and the Board of Directors’ constitutive meeting16.4.2024 14:40:00 CEST | Press release

Marimekko Corporation, Stock Exchange Release 16 April 2024 at 3.40 p.m. Resolutions of Marimekko Corporation’s Annual General Meeting and the Board of Directors’ constitutive meeting At Marimekko Corporation’s Annual General Meeting (the AGM), held today, and at the subsequent constitutive meeting of the Board of Directors, the following resolutions were passed. A. RESOLUTIONS OF THE ANNUAL GENERAL MEETING Adoption of the financial statements Marimekko Corporation’s income statement and balance sheet and the consolidated income statement and balance sheet for 2023 were adopted. Payment of dividend The AGM approved the Board of Directors’ proposal to distribute a dividend of EUR 0.37 per share for the financial year 2023. The dividend will be paid on 25 April 2024 to shareholders who are registered on the dividend payout record date of 18 April 2024 in the company’s shareholder register held by Euroclear Finland Ltd on behalf of the Board of Directors of the company. Discharge from lia

Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer16.4.2024 14:00:00 CEST | Press release

Dr. Khan, formerly the Chief Data Science Officer and Global Head of Strategy and Portfolio, Innovative Medicine R&D at Johnson & Johnson (J&J), will also join Recursion’s Board of Directors SALT LAKE CITY, April 16, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery and development, announced Najat Khan, PhD, will be its Chief R&D Officer and Chief Commercial Officer. Dr. Khan will lead Recursion’s research and development, and build its emerging commercial capabilities. She has also been appointed to Recursion’s Board of Directors. “Najat brings a unique blend of leadership in biological, chemical, and medical sciences, data science, and business,” said Chris Gibson, Co-Founder and CEO of Recursion. “More importantly, she has a vision and passion for transforming drug discovery and development that complements ours and she has a strong sense of urgency to accelerate the industry’s f

HiddenA line styled icon from Orion Icon Library.Eye